DEBIO 1143, an IAP inhibitor, reverses ovarian cancer cells carboplatin resistance and triggers apoptotic or necroptotic cell death

BenoîtThibault1, LudivineGenre1, Augustin Le Naour1, Clothilde Broca1, Eliane Mery1,
GrégoireVuagniaux2, Jean Pierre Delord1, NorbertWiedemann2 & Bettina Couderc1

Scientific Reportsvolume 8, Article number: 17862 (2018) 

 

  1. Institut Claudius Regaud – IUCT Oncopole, University Toulouse III, Toulouse, France.
  2. Debiopharm International SA, CH-1002, Lausanne, Switzerland.